In one, clarithromycin given orally for 8 weeks was reported to improve asthma quality of life scores and reduce airway IL-8 in patients with non-eosinophilic airway inflammation when compared to those with eosinophilic disease [33]. This evidence concerns the gene CXCL8 and inflammatory response.